| 32.23 0.69 (2.19%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 42.24 | 1-year : | 46.63 |
| Resists | First : | 36.17 | Second : | 39.93 |
| Pivot price | 32.18  |
|||
| Supports | First : | 30.09 | Second : | 25.03 |
| MAs | MA(5) : | 31.27  |
MA(20) : | 33.33 |
| MA(100) : | 34.24 |
MA(250) : | 38.14 |
|
| MACD | MACD : | -1.4 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 32.2 |
D(3) : | 18.9 |
| RSI | RSI(14): 40.4 |
|||
| 52-week | High : | 48.12 | Low : | 7.77 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ GMRE ] has closed below upper band by 49.0%. Bollinger Bands are 0.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 32.86 - 32.98 | 32.98 - 33.08 |
| Low: | 31.17 - 31.31 | 31.31 - 31.44 |
| Close: | 32 - 32.2 | 32.2 - 32.39 |
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Wed, 15 Oct 2025
Nov 4: Global Medical REIT to release third-quarter results; webcast and conference call follow Nov 5 - Stock Titan
Mon, 13 Oct 2025
Global Medical REIT raised to Buy-equivalent at Citizens (GMRE:NYSE) - Seeking Alpha
Mon, 13 Oct 2025
Global Medical REIT (NYSE:GMRE) Stock Rating Upgraded by Citizens Jmp - MarketBeat
Mon, 13 Oct 2025
Global Medical REIT (NYSE:GMRE) Upgraded on Transformation Upside - AskTraders.com
Mon, 13 Oct 2025
Citizens JMP Upgrades Global Medical REIT Inc(GMRE.US) to Buy Rating, Announces Target Price $40 - 富途牛牛
Fri, 10 Oct 2025
Colliers Securities Maintains Global Medical REIT Inc(GMRE.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Real Estate
|
|
|
Industry:
REIT - Healthcare Facilities
|
|
| Shares Out | 13 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 5.8 (%) |
| Held by Institutions | 68.3 (%) |
| Shares Short | 773 (K) |
| Shares Short P.Month | 558 (K) |
| EPS | 0.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 32.02 |
| Profit Margin | 7.2 % |
| Operating Margin | 23.6 % |
| Return on Assets (ttm) | 1.6 % |
| Return on Equity (ttm) | 1.9 % |
| Qtrly Rev. Growth | 10.6 % |
| Gross Profit (p.s.) | 10.56 |
| Sales Per Share | 10.58 |
| EBITDA (p.s.) | 6.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 71 (M) |
| Levered Free Cash Flow | 69 (M) |
| PE Ratio | 92.08 |
| PEG Ratio | 0 |
| Price to Book value | 1 |
| Price to Sales | 3.04 |
| Price to Cash Flow | 6.06 |
| Dividend | 0.75 |
| Forward Dividend | 0 |
| Dividend Yield | 2.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|